On Tuesday, July 30, Magellan Health MGLN will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.
Earnings and Revenue
Analysts covering Magellan Health modeled for quarterly EPS of 95 cents on revenue of $1.76 billion.
In the same quarter last year, Magellan Health reported EPS of 92 cents on revenue of $1.81 billion. If the company were to match the consensus estimate, earnings would be up 3.26%. Revenue would be down 2.82% from the same quarter last year. In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:
Quarter | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 |
EPS Estimate | 0.550 | 1.41 | 1.37 | 1.23 |
EPS Actual | 0.400 | 1.28 | 1.45 | 0.92 |
Stock Performance
Over the last 52-week period, shares are down 24.58%. Given that these returns are generally negative, long-term shareholders are probably unhappy going into this earnings release. Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The average rating by analysts on Magellan Health stock is a Neutral. The validity of this rating has maintained conviction over the past 90 days.
Conference Call
Magellan Health is scheduled to hold a conference call at 10:00 a.m. ET and can be accessed here: https://edge.media-server.com/mmc/p/xz39233u
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.